premature ovarian insufficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Volunteer to participate in this study, be willing to use medication according to the treatment plan and follow up, and sign the informed consent; 2. The patient was in good health, and there were no obvious abnormalities in clinical physical examination and laboratory examination (except for POI related indicators); 3. Aged between 20 and 40 years; Conforming to the preliminary screening conditions of POI (Poseidon Group 3 and Group 4) as ovarian basal sinus follicles less than 5; AMH <1.2ng/ml; 4. Hysteroscopy or fallopian tube examination: the uterine cavity shape is normal; normal uterine cavity shape after the operation drugs and the like; 5. The karyotype of the couple is normal and there is no genetic disease.
Exclusion criteria
Exclusion criteria: 1. Patients with severe diseases of the respiratory system or endocrine system or nervous system or cardiovascular system or diseases of the digestive system or genitourinary system or family history of hereditary diseases; 2. Who has suffered from or is suffering from contraindications of Zishen Yutai pills or alleric to Zishen Yutai pills; 3. Smoking more than 20 cigarettes a day; 4. Patients with genital tract virus infection and cervical laxity; With reproductive organ malformation or chromosome abnormality; 5. Patients with HBV, HCV, HIV or severe autoimmune diseases or tumors or cancers; 6. Patients with endometrial lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| oocyte utilization rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| implantation rate (number of pregnant cases which are confirmed by blood ß-hCG examination / number of transplanted cases);multiple pregnancy rate (Number of twins and above cases/number of pregnant cases which are confirmed by ultrasound);early miscarriage rate (number of miscarriage cases / number of pregnant cases confirmed by ultrasound);late miscarriage rate (number of miscarriage cases / number of pregnant cases confirmed by ultrasound);premature birth rate (number of premature births/ number of pregnant cases confirmed by ultrasound);live birth rate (number of deliveries / number of transplantation cycles);number of retrieved oocytes;fertilization rate (number of fertilized oocytes / number of retrieved oocytes);cleavage rate;Effective embryo rate;high qualified embryo rate;Adverse reaction rate;Cancellation rate;Clinical pregnancy rate (Clinical pregnancies/total number of embryo transfer cycles); | — |
Countries
China
Contacts
Reproductive Medical Center of Ruijin Hospital School of Medicine, Shanghai Jiaotong University